ESH 2026 – INNOVATIONS IN CARDIOMETABOLIC MANAGEMENT

UNITING GLOBAL EXPERTS TO SHAPE THE FUTURE OF CARDIOMETABOLIC CARE

Join Us in Gdańsk (Poland), May 28-31, 2026

 

Dear Colleagues,

We are delighted to invite you to the upcoming European Society of Hypertension (ESH) Congress, which will be held in the beautiful city of Gdańsk, Poland, from May 28 to 31, 2026.

Under the central theme “Innovations in Cardiometabolic Management”, the congress will highlight the latest breakthroughs and clinical advancements in the rapidly evolving field of cardiometabolic health – both within the scope of hypertension and across related areas.

Our scientific programme will feature cutting-edge research, spanning discovery science, clinical trials, novel diagnostics, and emerging therapeutic strategies. In parallel, a dedicated track for practicing clinicians will focus on real-world implementation, offering practical guidance for everyday clinical decision-making.

To encourage dynamic engagement and cross-disciplinary collaboration, the congress will offer a variety of innovative formats – including interactive sessions, hands-on workshops, expert panels, and more – ensuring that all participants gain valuable and applicable insights.

Let’s meet in Gdańsk to shape the future of cardiometabolic care together!

Prof. Andrzej Januszewicz                         Prof. Krzysztof Narkiewicz                        Prof. Thomas Weber
Co-Chair ESH 2026 Meeting                     Co-Chair ESH 2026 Meeting                     ESH President 2024-2026

 

IMPORTANT NOTICE: BEWARE OF UNOFFICIAL AGENCIES

We have been made aware that unauthorized companies are contacting faculty members and stakeholders, falsely claiming to offer access to the ESH 2026 attendee list.

Please be advised that these communications are fraudulent and should be treated as spam. Neither ESH nor AIM sell, share, or distribute participants’ contact details to any third parties.

We strongly recommend that you do not engage with these messages or provide any personal or professional information. If you receive such communications, please disregard them and report them as spam.